thursday

18

May
2017

PANEL: Cross-cutting Key Enabling Technologies (KETs) for health - hurdles & pitfalls and how to cope with them

View full programme

Bart Landuyt - Co-Founder, CellSine

Short description of the presentation:

A disruptive novel technology has been established by the universities of Brussels and Leuven to enable label-free, high-throughput drug discovery.

Biography:

Bart Landuyt obtained a master degree in bio-engineering (KU Leuven), a PhD in medical sciences – Oncology (KU Leuven), and an MBA (Vlerick business school). Bart works as a business development manager for the KU Leuven industrial research fund. Bart is founder of two biotech companies: DKR brewery (2010) and CellSine (2015).

PLATINUM SPONSORS

No Platinum sponsor yet.
Click here and become the first Platinum sponsor.

Gold sponsors

Silver sponsors